KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Accumulated Expenses: 2009-2024

Historic Accumulated Expenses for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $3.5 billion.

  • Bausch Health Companies' Accumulated Expenses rose 6.26% to $3.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year increase of 6.26%. This contributed to the annual value of $3.5 billion for FY2024, which is 11.36% up from last year.
  • Latest data reveals that Bausch Health Companies reported Accumulated Expenses of $3.5 billion as of FY2024, which was up 11.36% from $3.1 billion recorded in FY2023.
  • Bausch Health Companies' Accumulated Expenses' 5-year high stood at $4.8 billion during FY2021, with a 5-year trough of $3.0 billion in FY2022.
  • For the 3-year period, Bausch Health Companies' Accumulated Expenses averaged around $3.2 billion, with its median value being $3.1 billion (2023).
  • As far as peak fluctuations go, Bausch Health Companies' Accumulated Expenses plummeted by 37.63% in 2022, and later climbed by 11.36% in 2024.
  • Yearly analysis of 5 years shows Bausch Health Companies' Accumulated Expenses stood at $4.6 billion in 2020, then grew by 4.70% to $4.8 billion in 2021, then crashed by 37.63% to $3.0 billion in 2022, then grew by 4.85% to $3.1 billion in 2023, then grew by 11.36% to $3.5 billion in 2024.